Home › Interstitial Lung Diseases › Nebraska
Interstitial Lung Diseases clinical trials in Nebraska
3 studies for Interstitial Lung Diseases are looking for participants at sites in Nebraska.
Cities in Nebraska
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- University of Nebraska Medical Center, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06806592Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- CHI Health Creighton University Medical Center - Bergan Mercy, Omaha
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.